PRRT2 and acute lymphoblastic leukemia: Additionally, we have shown that, in spite of the existence of diverse mechanisms of cell adhesion [22,39,47,48], blocking B-ALL cell interactions with MSC by inhibiting MSC PKC activity has a drug sensitization effect in B-ALL cells [16].